Speaker Proposals Now Being Accepted

Couples experiencing infertility or failed pregnancy can now take advantage of a number of molecular diagnostic options to determine the health and wellness of their embryos as well as their own fertility. Cambridge Healthtech Institute’s Second Annual Reproductive Genetic Diagnostics conference examines the latest in preimplantation diagnostic and screening technologies, including their applications in assessing mtDNA load; determining aneuploidy through single-gene disorders; and assessing mosaicism. The meeting will also examine the potential for non-invasive PGD by blastocentesis, being developed in response to the potential effect biopsy and vitrification may have on the development of the embryo. There will be discussion on PGD for donor eggs, such as how much or how often testing should be done. The meeting will also cover advances in CRISPR, including current research and capabilities, as well as how this technology may or may not be used in the future. New this year, special attention will be paid to molecular diagnostics for finding infertility biomarkers in sperm and the uterus.

Topics may include, but are not limited to:

Advances and Challenges in PGD and PGS

  • For mtDNA load and mitochondrial disease, aneuploidy, single-gene disorders and more
  • Challenges with mosaicism
  • Potential for non-invasive PGD by blastocentesis
  • PGD use for donor eggs
  • NIPT as a follow up for PGD
  • Advances and ethical challenges of CRISPR and the potential for gene editing on human embryos

Embryology and PGD

  • Effect of biopsy on embryo development
  • Effect of vitrification on embryo

Diagnostics for Infertility

  • Diagnostics for sperm
  • Diagnostics on the uterus
  • Fertility biomarkers in the genome

Beyond Preimplantation Testing

  • Carrier screening and its role in the reproductive clinic
  • Product-of-conception testing and miscarriage beyond cytogenetics

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is May 20, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to clinicians, regulators and academics. Additionally, vendors/consultants who provide products, services, and technology to the audience are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Kaitlin Searfoss
Conference Producer
Cambridge Healthtech Institute
Phone: (+1) 781-972-5498
Email: ksearfoss@healthtech.com

For partnering and sponsorship information, please contact:
Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5457
Email: iquigley@healthtech.com

Who should attend:

  • Reproductive Endocrinologists
  • Embryologists
  • Cytogeneticists
  • Fertility Specialists
  • Maternal/Fetal Medicine
  • OB-GYN Physicians
  • Genetic Counselors
  • Andrologists